1hhu

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
[[Image:1hhu.jpg|left|200px]]
[[Image:1hhu.jpg|left|200px]]
-
{{Structure
+
<!--
-
|PDB= 1hhu |SIZE=350|CAPTION= <scene name='initialview01'>1hhu</scene>, resolution 0.89&Aring;
+
The line below this paragraph, containing "STRUCTURE_1hhu", creates the "Structure Box" on the page.
-
|SITE=
+
You may change the PDB parameter (which sets the PDB file loaded into the applet)
-
|LIGAND= <scene name='pdbligand=BMY:BALHIMYCIN'>BMY</scene>, <scene name='pdbligand=CIT:CITRIC+ACID'>CIT</scene>, <scene name='pdbligand=DAL:D-ALANINE'>DAL</scene>, <scene name='pdbligand=MPD:(4S)-2-METHYL-2,4-PENTANEDIOL'>MPD</scene>
+
or the SCENE parameter (which sets the initial scene displayed when the page is loaded),
-
|ACTIVITY=
+
or leave the SCENE parameter empty for the default display.
-
|GENE=
+
-->
-
|DOMAIN=
+
{{STRUCTURE_1hhu| PDB=1hhu | SCENE= }}
-
|RELATEDENTRY=
+
-
|RESOURCES=<span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1hhu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1hhu OCA], [http://www.ebi.ac.uk/pdbsum/1hhu PDBsum], [http://www.rcsb.org/pdb/explore.do?structureId=1hhu RCSB]</span>
+
-
}}
+
'''BALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA'''
'''BALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA'''
Line 19: Line 16:
==About this Structure==
==About this Structure==
-
1HHU is a [[Protein complex]] structure of sequences from [http://en.wikipedia.org/wiki/Amycolatopsis_sp. Amycolatopsis sp.]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HHU OCA].
+
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1HHU OCA].
==Reference==
==Reference==
Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors., Lehmann C, Bunkoczi G, Vertesy L, Sheldrick GM, J Mol Biol. 2002 May 3;318(3):723-32. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12054818 12054818]
Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors., Lehmann C, Bunkoczi G, Vertesy L, Sheldrick GM, J Mol Biol. 2002 May 3;318(3):723-32. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/12054818 12054818]
-
[[Category: Amycolatopsis sp.]]
 
-
[[Category: Protein complex]]
 
[[Category: Bunkoczi, G.]]
[[Category: Bunkoczi, G.]]
[[Category: Lehmann, C.]]
[[Category: Lehmann, C.]]
[[Category: Sheldrick, G M.]]
[[Category: Sheldrick, G M.]]
[[Category: Vertessy, L.]]
[[Category: Vertessy, L.]]
-
[[Category: cell wall peptide]]
+
[[Category: Cell wall peptide]]
-
[[Category: direct method]]
+
[[Category: Direct method]]
-
[[Category: glycopeptide]]
+
[[Category: Glycopeptide]]
-
[[Category: vacomycin]]
+
[[Category: Vacomycin]]
-
 
+
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 18:51:31 2008''
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Mar 30 21:05:11 2008''
+

Revision as of 15:51, 2 May 2008

Template:STRUCTURE 1hhu

BALHIMYCIN IN COMPLEX WITH D-ALA-D-ALA


Overview

The vancomycin-related antibiotics balhimycin and degluco-balhimycin have been crystallized in complexes with di-, tri- and pentapeptides that emulate bacterial cell-wall precursors, and four structures determined at atomic resolution (<1 A). In addition to the features expected from previous structural and spectroscopic studies, two new motifs were observed that may prove important in the design of antibiotics modified to overcome bacterial resistance. A changed binding mode was found in two dipeptide complexes, and a new type of face-to-face oligomerization (in addition to the well-established back-to-back dimerization) was seen when the model peptide reaches a critical fraction of the size of the cell-wall precursor pentapeptide. The extensive interactions involving both antibiotic and peptide molecules in this interface should appreciably enhance the kinetic and thermodynamic stability of the complexes. In the pentapeptide complex, the relative positions of the peptides are close to those required for d-Ala elimination, so this structure may provide a realistic model for the prevention of the enzyme-catalyzed cell-wall crosslinking by antibiotic binding.

About this Structure

Full crystallographic information is available from OCA.

Reference

Structures of glycopeptide antibiotics with peptides that model bacterial cell-wall precursors., Lehmann C, Bunkoczi G, Vertesy L, Sheldrick GM, J Mol Biol. 2002 May 3;318(3):723-32. PMID:12054818 Page seeded by OCA on Fri May 2 18:51:31 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools